Klp Kapitalforvaltning As Biotechnology

Klp Kapitalforvaltning As

$20.6 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$119B	$35 Million 0.17% of portfolio	86,941	Q4 2024 New
REGN Regeneron Pharmaceuticals, Inc.	$72.3B	$34.5 Million 0.17% of portfolio	48,388	Q4 2024 New
UTHR United Therapeutics Corp	$16.9B	$15.3 Million 0.07% of portfolio	43,300	Q4 2024 New
ALNY Alnylam Pharmaceuticals, Inc.	$32.6B	$10.3 Million 0.05% of portfolio	43,700	Q4 2024 New
MRNA Moderna, Inc.	$12.5B	$4.44 Million 0.02% of portfolio	106,800	Q4 2024 New
BMRN Biomarin Pharmaceutical Inc	$12B	$4.39 Million 0.02% of portfolio	66,737	Q4 2024 New
EXEL Exelixis, Inc.	$11.1B	$3.8 Million 0.02% of portfolio	114,200	Q4 2024 New
INCY Incyte Corp	$15.6B	$3.79 Million 0.02% of portfolio	54,805	Q4 2024 New
TECH Bio Techne Corp	$2.62B	$3.77 Million 0.02% of portfolio	52,400	Q4 2024 New
RPRX Royalty Pharma PLC	$14.2B	$3.15 Million 0.02% of portfolio	123,300	Q4 2024 New
INSM Insmed Inc	$10.7B	$2.28 Million 0.01% of portfolio	33,000	Q4 2024 New
SRPT Sarepta Therapeutics, Inc.	$9.59B	$2.16 Million 0.01% of portfolio	17,800	Q4 2024 New
JAZZ Jazz Pharmaceuticals PLC	$8.58B	$2.09 Million 0.01% of portfolio	17,000	Q4 2024 New
PCVX Vaxcyte, Inc.	$4.97B	$1.84 Million 0.01% of portfolio	22,500	Q4 2024 New
CORT Corcept Therapeutics Inc	$7.88B	$1.34 Million 0.01% of portfolio	26,600	Q4 2024 New
INVA Innoviva, Inc.	$1.27B	$1.26 Million 0.01% of portfolio	72,400	Q4 2024 New
HALO Halozyme Therapeutics, Inc.	$8.16B	$1.25 Million 0.01% of portfolio	26,200	Q4 2024 New
BPMC Blueprint Medicines Corp	$5.68B	$1.13 Million 0.01% of portfolio	12,900	Q4 2024 New
CYTK Cytokinetics Inc	$3.92B	$1.08 Million 0.01% of portfolio	23,000	Q4 2024 New
RVMD Revolution Medicines, Inc.	$3.62B	$1.03 Million 0.0% of portfolio	23,504	Q4 2024 New
IONS Ionis Pharmaceuticals Inc	$4.31B	$1.02 Million 0.0% of portfolio	29,200	Q4 2024 New
TGTX Tg Therapeutics, Inc.	$4.46B	$924,000 0.0% of portfolio	30,700	Q4 2024 New
ROIV Roivant Sciences Ltd.	$7.36B	$918,000 0.0% of portfolio	77,600	Q4 2024 New
VKTX Viking Therapeutics, Inc.	$2.26B	$832,000 0.0% of portfolio	20,700	Q4 2024 New
CRNX Crinetics Pharmaceuticals, Inc.	$1.9B	$818,000 0.0% of portfolio	16,000	Q4 2024 New
MDGL Madrigal Pharmaceuticals, Inc.	$6.02B	$802,000 0.0% of portfolio	2,600	Q4 2024 New
ADMA Adma Biologics, Inc.	$3.16B	$794,000 0.0% of portfolio	46,300	Q4 2024 New
HRMY Harmony Biosciences Holdings, Inc.	$2.31B	$791,000 0.0% of portfolio	23,000	Q4 2024 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.39B	$772,000 0.0% of portfolio	37,000	Q4 2024 New
AXSM Axsome Therapeutics, Inc.	$5.65B	$744,000 0.0% of portfolio	8,800	Q4 2024 New
BBIO Bridge Bio Pharma, Inc.	$4.68B	$692,000 0.0% of portfolio	25,235	Q4 2024 New
RARE Ultragenyx Pharmaceutical Inc.	$3.05B	$685,000 0.0% of portfolio	16,300	Q4 2024 New
KRYS Krystal Biotech, Inc.	$4B	$673,000 0.0% of portfolio	4,300	Q4 2024 New
VNDA Vanda Pharmaceuticals Inc.	$266M	$648,000 0.0% of portfolio	135,400	Q4 2024 New
PTCT Ptc Therapeutics, Inc.	$3.55B	$645,000 0.0% of portfolio	14,300	Q4 2024 New
CRSP Crispr Therapeutics Ag	$3.39B	$633,000 0.0% of portfolio	16,100	Q4 2024 New
VCYT Veracyte, Inc.	$2.83B	$609,000 0.0% of portfolio	15,400	Q4 2024 New
LEGN Legend Biotech Corp	$6.09B	$598,000 0.0% of portfolio	18,400	Q4 2024 New
NUVL Nuvalent, Inc.	$3.48B	$594,000 0.0% of portfolio	7,600	Q4 2024 New
VCEL Vericel Corp	$2.68B	$538,000 0.0% of portfolio	9,800	Q4 2024 New
SRRK Scholar Rock Holding Corp	$1.94B	$535,000 0.0% of portfolio	12,400	Q4 2024 New
DNLI Denali Therapeutics Inc.	$2.86B	$531,000 0.0% of portfolio	26,100	Q4 2024 New
RNA Avidity Biosciences, Inc.	$1.72B	$520,000 0.0% of portfolio	17,900	Q4 2024 New
RYTM Rhythm Pharmaceuticals, Inc.	$3.21B	$519,000 0.0% of portfolio	9,300	Q4 2024 New
APLS Apellis Pharmaceuticals, Inc.	$3.02B	$504,000 0.0% of portfolio	15,800	Q4 2024 New
ACLX Arcellx, Inc.	$2.79B	$502,000 0.0% of portfolio	6,600	Q4 2024 New
XENE Xenon Pharmaceuticals Inc.	$2.44B	$501,000 0.0% of portfolio	12,800	Q4 2024 New
FOLD Amicus Therapeutics, Inc.	$2.7B	$461,000 0.0% of portfolio	49,000	Q4 2024 New
SWTX Spring Works Therapeutics, Inc.	$3.66B	$455,000 0.0% of portfolio	12,600	Q4 2024 New
JANX Janux Therapeutics, Inc.	$1.55B	$449,000 0.0% of portfolio	8,400	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.